| pubmed-article:19343004 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19343004 | lifeskim:mentions | umls-concept:C0002210 | lld:lifeskim |
| pubmed-article:19343004 | lifeskim:mentions | umls-concept:C0001418 | lld:lifeskim |
| pubmed-article:19343004 | lifeskim:mentions | umls-concept:C0069717 | lld:lifeskim |
| pubmed-article:19343004 | lifeskim:mentions | umls-concept:C0671970 | lld:lifeskim |
| pubmed-article:19343004 | lifeskim:mentions | umls-concept:C0205144 | lld:lifeskim |
| pubmed-article:19343004 | lifeskim:mentions | umls-concept:C2003874 | lld:lifeskim |
| pubmed-article:19343004 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:19343004 | pubmed:dateCreated | 2009-4-3 | lld:pubmed |
| pubmed-article:19343004 | pubmed:abstractText | Alpha-fetoprotein-producing metastatic adenocarcinoma of the stomach or the esophago-gastric junction usually exhibits either no or only short-term remission while receiving palliative chemotherapy. We report on a 76-year-old male patient suffering from an unresectable alpha-fetoprotein-producing adenocarcinoma of the esophago-gastric junction with several liver metastases. He was treated with capecitabine and oxaliplatin-based combination therapy. A long-lasting major remission was observed resulting in a survival of 18.5 months. | lld:pubmed |
| pubmed-article:19343004 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19343004 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19343004 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19343004 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19343004 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19343004 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19343004 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19343004 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19343004 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:19343004 | pubmed:issn | 1473-5741 | lld:pubmed |
| pubmed-article:19343004 | pubmed:author | pubmed-author:StröbelPhilip... | lld:pubmed |
| pubmed-article:19343004 | pubmed:author | pubmed-author:HochhausAndre... | lld:pubmed |
| pubmed-article:19343004 | pubmed:author | pubmed-author:HofheinzRalf-... | lld:pubmed |
| pubmed-article:19343004 | pubmed:author | pubmed-author:DinterDietmar... | lld:pubmed |
| pubmed-article:19343004 | pubmed:author | pubmed-author:LukanNadineN | lld:pubmed |
| pubmed-article:19343004 | pubmed:author | pubmed-author:KrippMelanieM | lld:pubmed |
| pubmed-article:19343004 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19343004 | pubmed:volume | 20 | lld:pubmed |
| pubmed-article:19343004 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19343004 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19343004 | pubmed:pagination | 75-8 | lld:pubmed |
| pubmed-article:19343004 | pubmed:meshHeading | pubmed-meshheading:19343004... | lld:pubmed |
| pubmed-article:19343004 | pubmed:meshHeading | pubmed-meshheading:19343004... | lld:pubmed |
| pubmed-article:19343004 | pubmed:meshHeading | pubmed-meshheading:19343004... | lld:pubmed |
| pubmed-article:19343004 | pubmed:meshHeading | pubmed-meshheading:19343004... | lld:pubmed |
| pubmed-article:19343004 | pubmed:meshHeading | pubmed-meshheading:19343004... | lld:pubmed |
| pubmed-article:19343004 | pubmed:meshHeading | pubmed-meshheading:19343004... | lld:pubmed |
| pubmed-article:19343004 | pubmed:meshHeading | pubmed-meshheading:19343004... | lld:pubmed |
| pubmed-article:19343004 | pubmed:meshHeading | pubmed-meshheading:19343004... | lld:pubmed |
| pubmed-article:19343004 | pubmed:meshHeading | pubmed-meshheading:19343004... | lld:pubmed |
| pubmed-article:19343004 | pubmed:meshHeading | pubmed-meshheading:19343004... | lld:pubmed |
| pubmed-article:19343004 | pubmed:meshHeading | pubmed-meshheading:19343004... | lld:pubmed |
| pubmed-article:19343004 | pubmed:meshHeading | pubmed-meshheading:19343004... | lld:pubmed |
| pubmed-article:19343004 | pubmed:meshHeading | pubmed-meshheading:19343004... | lld:pubmed |
| pubmed-article:19343004 | pubmed:meshHeading | pubmed-meshheading:19343004... | lld:pubmed |
| pubmed-article:19343004 | pubmed:meshHeading | pubmed-meshheading:19343004... | lld:pubmed |
| pubmed-article:19343004 | pubmed:meshHeading | pubmed-meshheading:19343004... | lld:pubmed |
| pubmed-article:19343004 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19343004 | pubmed:articleTitle | Alpha-fetoprotein expressing metastastic adenocarcinoma of the esophago-gastric junction responding favorably to capecitabine and oxaliplatin. | lld:pubmed |
| pubmed-article:19343004 | pubmed:affiliation | Onkologisches Zentrum, III. Medizinische Klinik, Medizinische Fakultät Mannheim der Universität Heidelberg, Mannheim, Germany. melanie.kripp@med3.ma.uni-heidelberg.de | lld:pubmed |
| pubmed-article:19343004 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19343004 | pubmed:publicationType | Case Reports | lld:pubmed |
| entrez-gene:174 | entrezgene:pubmed | pubmed-article:19343004 | lld:entrezgene |
| http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:19343004 | lld:entrezgene |
